Download PDF
Allgemeine Homöopathische Zeitung 2020; 265(06): 17-23
DOI: 10.1055/a-1272-6504
Materia medica

Withania somnifera – ein neues homöopathisches Arzneimittel

Ulrich Koch
› Further Information
    Permissions and Reprints

Zusammenfassung

Withania somnifera ist in den traditionellen Medizinsystemen Indiens und Afrikas seit Jahrtausenden als wichtige Arzneipflanze bekannt. Es wird synoptisch über 3 hochqualitative Arzneimittelprüfungen berichtet, die insgesamt Symptome für mehr als 300 Rubriken ergaben, und es werden die wichtigsten Aspekte herausgearbeitet, die eine Anwendung dieser für die Homöopathie neuen Arznei erleichtern sollen.

Summary

Withania somnifera has been known as an important medicinal plant in the traditional medical systems of India and Africa for thousands of years. Three high quality pathogenetic trials are reported synoptically, which in total revealed symptoms for more than 300 categories and the most important aspects are identified to facilitate the use of this new homeopathic remedy.

Schlüsselwörter

Withania somnifera - Schlafbeere - homöopathische Arzneimittelprüfung

Key words

Withania somnifera - Indian Winter Cherry - homeopathic pathogenetic trial


Publication History

Article published online:
23 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Bielenberg J. Withania somnifera (Indischer Ginseng / Schlafbeere): Hypnotikum mit neuroprotektiven Effekten. Neuro Aktuell 2019; 5: 23-28
    Google Scholar
  • 2 Datta AK, Das A, Bhattacharya A. et al. An overview on Withania somnifera (L.) Dunal: The Indian Ginseng. Medicinal and Aromatic Plant Science and Biotechnology 2011; 5 (01) : 1-15
    PubMedGoogle Scholar
  • 3 Kaul SC, Wadhwa R. eds. Science of Ashwagandha: Preventive and Therapeutic Potentials. New York: Springer; 2017
    CrossrefGoogle Scholar
  • 4 Laidlaw M. A homeopathic drug proving of Withania somnifera 30CH. Dissertation. Durban: Durban University; 2016. Im Internet:. http://hdl.handle.net/10321/1515; Stand: 20.9.2020
    Google Scholar
  • 5 Mehra P, Khurana A, Mittal R. et al. Homoeopathic pathogenetic trial of Withania somnifera: A multicentric, double blind, randomized, placebo-controlled trial. Indian J Research Homoeopathy 2017; 11: 97-108
    CrossrefGoogle Scholar
  • 6 Pillay NN. A Homoeopathic C4 trituration proving of Withania somnifera with a subsequent comparison to the conventional 30CH proving of Withania somnifera. Dissertation. Durban: Durban University; 2017. Im Internet:. http://hdl.handle.net/10321/2916; Stand: 20.9.2020
    Google Scholar
  • 7 Teut M, Dahler J, Lucae C, Koch U. Kursbuch Homöopathie. München: Elsevier; 2016
    Google Scholar
  • 8 Tripathi MK, Singh P, Sharma S. et al. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics. 2020 Im Internet:. DOI: https://doi.org/10.1080/07391102.2020.1790425; Stand: 20.9.2020
    CrossrefGoogle Scholar
  • 9 Umadevi M, Rajeswari R, Rahale CS. et al. Traditional and medicinal uses of Withania somnifera. The Pharma Journal 2012; 1 (09) : 102-110
    Google Scholar
  • 10 Zahiruddin S, Basist P, Parveen A. et al. Ashwagandha in brain disorders: A review of recent developments. Journal of Ethnopharmacology 2020; 257
    Google Scholar
  • 11 Zoller A, Nordwig H. Heilpflanzen der ayurvedischen Medizin. Kandern: Narayana; 2012
    Google Scholar